It was noted, late in the day, that Roche launched a $16 billion, six-part debt offering. This is the largest single deal ever in the U.S. corporate bond market. It is going to help fund the buyout of Genentech.

If a deal can be made. They have offered $86.50 for the company; minority shareholders want $112 a share.